Route of administration characterized by deposition in the nasal cavity for local or systemic effect.
Glossary
Nasal
03.29.12
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE, Selecta Biosciences Form Mfg. Pact
LSNE to provide drug substance manufacturing and fill/finish services
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
Nektar and Takeda in Research Collaboration
Will explore combination cancer therapies
-
Elemental Impurities: A Virtual Company Perspective
A look at risk assessments for elemental impurity determinations in oral tablet and parenteral drug products.Anthony DeStefano and Thomas Kester, Recordati Rare Diseases, Inc.
-
Bioanalytical Services | Drug Development | Drug Discovery | Industry News | Methods Development
Diteba Develops IV Approach to Achieve Biowaiver Status
novel approach to qualify acyclovir cream products for biowaiver status, potentially replacing clinical trials
